Theophylline
NDC 70771-1782, Theophylline, tablet, extended release, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1782
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218063
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1782 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS300 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1782-1 | 70771178201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1782-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7339f98d-b996-4e20-a7a7-315fd2a9fa4d
Use it
Look up 70771-1782 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1782 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1782. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.